Dolphin Neurostim
- Company typePrivate
- Founded1989
- HeadquartersToronto, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Dolphin Neurostim firmographics
Firmographics- Name
- Dolphin Neurostim
- Legal name
- Center for Pain and Stress Research
- Website
- https://dolphinmps.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Dolphin Neurostim industry classification
Industry- Product category
- Microcurrent Pain Management Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)
- akta.pro secondary industries
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)
Keywords
Where Dolphin Neurostim is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Dolphin Neurostim business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Dolphin Neurostim Hardware Sales: Sale of the Dolphin Neurostim device and kits. Products include Pain Management Kit ($424), Scar Release Kit ($749), various VNS combination kits, and upgrade packages. One-time hardware purchase with 1-year warranty and 30-day money-back guarantee.
- Accessories and Consumables: Sales of accessories including holsters ($25-$30), dual wrist straps ($25), extension probes ($25), deluxe carrying cases ($40), and electrode pads. Ongoing accessory purchases complement the device.
- MPS Education and Training Courses: Online and in-person certification courses for healthcare professionals. Courses include Intro to MPS Pain Therapy (12 CEs, $399), Scar Release Therapy (12 CEs, $499), Advanced Auricular Therapy (12 CEs, $499), and specialized courses like Brain Healing/Concussion protocols. Courses serve as both revenue stream and customer acquisition driver.
- Educational Content and DVDs: Sale of educational materials including DVDs and USB content such as 'Kinetic Chain Patterns And MPS Scar Therapy For Complicated Shoulder Conditions' ($60).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Dolphin Pain Management Kit - Entry-level professional device |
| Unit Pricing | Pay-as-you-go | Dolphin Scar Release Kit - Advanced dual-unit kit for comprehensive therapy |
| Unit Pricing | Pay-as-you-go | Dolphin Pain Management + VNS Kit - Pain management with vagus nerve stimulation |
| Unit Pricing | Pay-as-you-go | Dolphin Scar Release + VNS Kit - Full-featured professional kit |
| Unit Pricing | Pay-as-you-go | Vagus Nerve Stim Kit - Accessory add-on for existing customers |
| Unit Pricing | Pay-as-you-go | Dolphin Single Unit Upgrade - Upgrade older model devices |
| Unit Pricing | Pay-as-you-go | Dolphin Double Unit Upgrade - Dual-unit upgrade package |
| Unit Pricing | Pay-as-you-go | MPS Pain Therapy Introductory Online Course |
| Unit Pricing | Pay-as-you-go | MPS Scar Release Therapy Online Course |
| Unit Pricing | Pay-as-you-go | Advanced MPS Auricular Therapy Online Course |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Dolphin Neurostim product offering
Product offeringCore offering
Dolphin Neurostim manufactures and sells FDA-cleared Class II medical devices that deliver Direct Current (DC) Microcurrent Point Stimulation (MPS) to acupuncture, trigger, and vagus nerve points for pain management, scar release, and nervous system regulation. The product line spans dedicated pain management and scar release kits, vagus nerve stimulation (VNS) kits, accessories, upgrade packages, and a portfolio of CE-accredited online certification courses for healthcare professionals.
Product overview
Dolphin Neurostim offers a portfolio of medical devices and educational courses centered around Microcurrent Point Stimulation (MPS) therapy. The core product line consists of the Dolphin Neurostim device, available in several kit configurations: the Dolphin Pain Management Kit (USD $424), the Dolphin Scar Release Kit (USD $749), and combination kits with Vagus Nerve Stimulation (VNS) accessories. Upgrade packages are available for customers with older Dolphin models. The product portfolio also includes accessories such as holsters, wrist straps, extension probes, and carrying cases. Educational offerings include online and live courses for MPS Pain Therapy, Scar Release Therapy, Auricular Therapy, Concussion/Brain Healing, Sensory Balancing, and Pelvic Floor Therapy, with CEU credits available. The company has been in business for over 36 years, with the device FDA Cleared and Health Canada Licenced.
Differentiator
Problem solved
Functional benefit
Products and services
- Dolphin Pain Management Kit
Quantifiable outcome
- 82% pain relief reported in published study (OGN Int Med 2019)
- +14 more outcomes
Companies that use Dolphin Neurostim
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
Dolphin Neurostim technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Dolphin Neurostim partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Acumed Medical, Ltd.coreAcumed Medical, Ltd. serves as the US supplier for Dolphin Neurostim products. Contact information includes phone 1-800-567-7246 and email [email protected]. Handles US distribution and customer support.
Scale indicators6 records
Recent moves5 records
Dolphin Neurostim competitors and assessment
Company assessmentBroad incumbents
- Chattanooga Group (DJO): DJO/Chattanooga is a major rehabilitation and pain management equipment manufacturer with professional-channel distribution. Both serve physiotherapists, chiropractors, and pain clinics, though DJO's portfolio spans far more modalities than MPS-specific microcurrent therapy.
- Omron Healthcare: Omron is a global incumbent in personal TENS/pain management devices with broad retail distribution (pharmacies, mass retail). Both sell FDA-cleared TENS-class devices for pain relief, but Omron competes at mass-market price points and scale rather than the clinical DC microcurrent niche.
- LivaNova: LivaNova (formerly Cyberonics) is the leading implantable vagus nerve stimulation company with extensive clinical evidence in epilepsy, depression, and heart failure. While Dolphin's VNS is non-invasive auricular stimulation, LivaNova represents the clinical gold standard and validates the VNS therapeutic area Dolphin is expanding into.
Emerging players
- Cala Health: Cala Health develops wearable transcutaneous afferent patterned stimulation (TAPS) therapy for essential tremor and is expanding into other indications. Both are emerging neuromodulation companies pursuing clinical evidence and prescription-adjacent positioning, though Cala focuses on tremor while Dolphin focuses on pain/scar/VNS.
- AxioBionics: AxioBionics develops wearable neurostimulation and electrical therapy devices for pain and muscle rehabilitation. Both operate in the electrotherapy category serving practitioners and patients, though AxioBionics focuses on functional electrical stimulation (FES) more than MPS.
Direct peers
- iTENS: iTENS manufactures and sells TENS devices directly to consumers for pain management, similar to Dolphin's OTC positioning. Both compete in the consumer-friendly transcutaneous electrotherapy category, though Dolphin differentiates on DC microcurrent vs. iTENS's standard TENS approach.
- BioElectronics Corporation: BioElectronics manufactures ActiPatch and RecoveryRx pulsed shortwave therapy devices for pain management and recovery. Both target the same OTC pain management consumer with FDA-cleared electrotherapy alternatives to drugs and traditional TENS.
- electroCore: electroCore markets gammaCore, a non-invasive vagus nerve stimulation device for headache and migraine. Both Dolphin (via its VNS accessory) and electroCore compete in non-invasive VNS for clinical and consumer use, with overlapping indications in headache/migraine pain management.
- Avacen Medical: Avacen markets FDA-cleared thermal circulation enhancement devices for pain management, competing in the same non-pharmaceutical pain relief category as Dolphin. Both pursue OTC and professional channels with clinical evidence supporting non-invasive pain therapy.
- NeuroMetrix: NeuroMetrix markets wearable neurostimulation devices (e.g., Quell) for chronic pain. Both companies pursue prescription-adjacent, OTC-electrotherapy positioning for pain management and have similar regulatory pathways and clinical-evidence-driven marketing strategies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Dolphin Neurostim social profiles
Digital presenceDolphin Neurostim compliance and trust
Trust signalCompliance2 records
Dolphin Neurostim financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dolphin Neurostim leadership team
Management profileNumber of profiles
Profiles1 record
Dolphin Neurostim funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dolphin Neurostim M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dolphin Neurostim
What does Dolphin Neurostim do?
Dolphin Neurostim manufactures and sells FDA-cleared Class II medical devices that deliver Direct Current (DC) Microcurrent Point Stimulation (MPS) to acupuncture, trigger, and vagus nerve points for pain management, scar release, and nervous system regulation. The product line spans dedicated pain management and scar release kits, vagus nerve stimulation (VNS) kits, accessories, upgrade packages, and a portfolio of CE-accredited online certification courses for healthcare professionals.
Is Dolphin Neurostim a public or private company?
Dolphin Neurostim is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dolphin Neurostim founded?
Dolphin Neurostim was founded in 1989. It employs 11 to 50 people.
Where is Dolphin Neurostim based?
Dolphin Neurostim is headquartered in Toronto, Canada, in the North America region.
How does Dolphin Neurostim make money?
Four revenue lines are on record. Dolphin Neurostim Hardware Sales are the primary driver. The others are accessories and Consumables, MPS Education and Training Courses and educational Content and DVDs.
Who are Dolphin Neurostim's main competitors?
Broad incumbents on record are Chattanooga Group (DJO), Omron Healthcare and LivaNova. Emerging players are Cala Health and AxioBionics. Direct peers are iTENS, BioElectronics Corporation, electroCore, Avacen Medical and NeuroMetrix.
Does Dolphin Neurostim have an API?
No public API is recorded for Dolphin Neurostim.
What industry is Dolphin Neurostim in?
Dolphin Neurostim's product category is Microcurrent Pain Management Devices. Its primary akta.pro industry code is CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices), with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.